Senior insider sale
Chief Medical Officer at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$254.4K
15.19K shares
What this filing means
FARAJALLAH AWNY SAMAAN BOTROS plans to sell 15.19K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $254.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/13/2026ACC: 0001395064-26-000307
Officer· Chief Medical Officer
Since Apr 2026
15.19K
Shares to sell
$254.4K
Approx. market value
38.98K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2026
38.98KTotal acquired38.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Restricted Stock Unit Awards - Vested. Compensation | 38.98K | — |
| Total | 38.98K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
15.19K
Market value
$254.4K
7/13/2026
Total
Units
15.19K
Value
$254.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/13/2026 | 15.19K | $254.4K | NYSE | Planned |
| Total | 15.19K | $254.4K | ||